• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 15-12G filed by Panacea Acquisition Corp. II

    4/28/23 1:18:26 PM ET
    $PANA
    Blank Checks
    Finance
    Get the next $PANA alert in real time by email
    15-12G 1 ea177667-1512g_panacea2.htm FORM 15-12G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 15

     

    CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
    UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
    OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
    OF THE SECURITIES EXCHANGE ACT OF 1934.

     

    Commission File Number 001-40311                    

     

    Panacea Acquisition Corp. II
    (Exact name of registrant as specified in its charter)

     

    357 Tehama Street, Floor 3

    San Francisco, CA 94103

    (415) 966-0807

    (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

     

    Class A ordinary shares, par value $0.0001 per share

    (Title of each class of securities covered by this Form)

     

    None

    (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

     

    Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

     

      Rule 12g-4(a)(1) ☒
      Rule 12g-4(a)(2) ☐
      Rule 12h-3(b)(1)(i) ☒
      Rule 12h-3(b)(1)(ii) ☐
      Rule 15d-6 ☐
      Rule 15d-22(b) ☐

     

    Approximate number of holders of record as of the certification or notice date:       1     

     

     

     

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, Panacea Acquisition Corp. II has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

     

    Date: April 28, 2023   By: /s/ Scott Perlen
          Name: Scott Perlen
          Title: Chief Financial Officer

     

     

     

     

    Get the next $PANA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PANA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $PANA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nuvation Bio Closes Transaction with Panacea, Debuts as Publicly Traded Oncology Company

    NEW YORK, Feb. 10, 2021 /PRNewswire/ -- Nuvation Bio Inc., a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the completion of its business combination with Panacea Acquisition Corp. (NYSE: PANA), a special purpose acquisition company (SPAC) sponsored by EcoR1 Capital. The resulting combined company will commence trading its shares on the New York Stock Exchange (NYSE) under the ticker symbol "NUVB" on February 11, 2021. The business combination was approved by Panacea's shareholders on February 9, 2021 and was previously approved by Nuvation Bio shareholders. Nuvation Bio's man

    2/10/21 4:05:00 PM ET
    $PANA
    Blank Checks
    Finance

    $PANA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Ecor1 Panacea Holdings Ii, Llc

    4 - Panacea Acquisition Corp. II (0001828989) (Issuer)

    5/2/23 5:15:46 PM ET
    $PANA
    Blank Checks
    Finance

    SEC Form 4: EcoR1 Panacea Holdings II, LLC bought $5,450,000 worth of Class A ordinary shares (545,000 units at $10.00)

    4 - Panacea Acquisition Corp. II (0001828989) (Issuer)

    4/13/21 3:10:13 PM ET
    $PANA
    Blank Checks
    Finance

    SEC Form 3 filed by Llc Ii, Holdings Panacea Ecor1

    3 - Panacea Acquisition Corp. II (0001828989) (Issuer)

    4/6/21 8:37:38 PM ET
    $PANA
    Blank Checks
    Finance

    $PANA
    SEC Filings

    View All

    SEC Form 15-12G filed by Panacea Acquisition Corp. II

    15-12G - Panacea Acquisition Corp. II (0001828989) (Filer)

    4/28/23 1:18:26 PM ET
    $PANA
    Blank Checks
    Finance

    SEC Form 25-NSE filed by Panacea Acquisition Corp. II

    25-NSE - Panacea Acquisition Corp. II (0001828989) (Subject)

    4/18/23 4:29:11 PM ET
    $PANA
    Blank Checks
    Finance

    Panacea Acquisition Corp. II filed SEC Form 8-K: Other Events

    8-K - Panacea Acquisition Corp. II (0001828989) (Filer)

    4/10/23 4:11:09 PM ET
    $PANA
    Blank Checks
    Finance

    $PANA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Panacea Acquisition Corp. II (Amendment)

    SC 13G/A - Panacea Acquisition Corp. II (0001828989) (Subject)

    2/14/24 4:01:16 PM ET
    $PANA
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Panacea Acquisition Corp. II (Amendment)

    SC 13G/A - Panacea Acquisition Corp. II (0001828989) (Subject)

    2/14/23 8:02:36 AM ET
    $PANA
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Panacea Acquisition Corp. II (Amendment)

    SC 13G/A - Panacea Acquisition Corp. II (0001828989) (Subject)

    2/14/23 7:34:59 AM ET
    $PANA
    Blank Checks
    Finance